Ftse Mib
36.147,34
-0,12%
DAX
21.430,58
0,71%
S&P 500
6.047,98
0,59%
NASDAQ
19.564,77
1,15%
Bitcoin
102.514,16
0,44%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Renovaro Inc (RENB) Renovaro Inc (RENB) Notizie

RENB

Renovaro (RENB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RENB
DataOraFonteTitoloSimboloCompagnia
13/01/202522:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RENBRenovaro Inc
13/01/202522:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RENBRenovaro Inc
07/01/202515:15GlobeNewswire Inc.Renovaro Issues Shareholder Letter and Provides Corporate UpdateNASDAQ:RENBRenovaro Inc
07/01/202515:15GlobeNewswire Inc.Renovaro Appoints Nathen Fuentes as Chief Financial OfficerNASDAQ:RENBRenovaro Inc
06/01/202515:15GlobeNewswire Inc.Renovaro to Acquire Predictive Oncology in All-Stock TransactionNASDAQ:RENBRenovaro Inc
30/12/202415:00GlobeNewswire Inc.Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BVNASDAQ:RENBRenovaro Inc
23/12/202415:00GlobeNewswire Inc.RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding ProgramNASDAQ:RENBRenovaro Inc
20/12/202421:40GlobeNewswire Inc.Renovaro Regains Compliance with NASDAQ Listing RequirementNASDAQ:RENBRenovaro Inc
20/12/202415:00GlobeNewswire Inc.Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease DetectionNASDAQ:RENBRenovaro Inc
14/11/202422:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RENBRenovaro Inc
07/11/202418:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RENBRenovaro Inc
07/11/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RENBRenovaro Inc
06/11/202423:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RENBRenovaro Inc
30/10/202421:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RENBRenovaro Inc
29/10/202421:21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:RENBRenovaro Inc
28/10/202422:10Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:RENBRenovaro Inc
17/10/202415:15GlobeNewswire Inc.RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore SequencingNASDAQ:RENBRenovaro Inc
16/10/202415:28GlobeNewswire Inc.Renovaro Announces Strategic Restructuring and Leadership TransitionNASDAQ:RENBRenovaro Inc
10/10/202422:33Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RENBRenovaro Inc
01/10/202422:02Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:RENBRenovaro Inc
19/09/202415:00GlobeNewswire Inc.PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care DiagnosticsNASDAQ:RENBRenovaro Inc
17/09/202415:00GlobeNewswire Inc.Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer DetectionNASDAQ:RENBRenovaro Inc
13/09/202415:00GlobeNewswire Inc.RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology CongressNASDAQ:RENBRenovaro Inc
11/09/202415:15GlobeNewswire Inc.RenovaroCube Announces Strategic Offering of Up to 20% OwnershipNASDAQ:RENBRenovaro Inc
20/08/202413:53Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:RENBRenovaro Inc
16/08/202422:43Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RENBRenovaro Inc
14/06/202415:06GlobeNewswire Inc.Renovaro, Inc. Announces $10 million in Equity CommittedNASDAQ:RENBRenovaro Inc
11/06/202417:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RENBRenovaro Inc
24/05/202415:20GlobeNewswire Inc.Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer ImmunotherapyNASDAQ:RENBRenovaro Inc
18/05/202403:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RENBRenovaro Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RENB

La tua Cronologia

LSE
80BF
Anz Bank 47
BIT
UIG168
Unicredit Bank
ASX
DBF
Duxton Broadacre Farms
LSE
HEVS
Hsbc Msci Emesg
BIT
P12A75
BNP PARIBAS ISSUANCE
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network